Wu EQ - Search Results

1

Outcomes in atrial fibrillation patients on combined warfarin & antiarrhythmic therapy.

Guérin A, Lin J, Jhaveri M, Wu EQ, Yu AP, Cloutier M, Gauthier G, Alpert JS. Guérin A, et al. Among authors: wu eq. Int J Cardiol. 2013 Jul 31;167(2):564-9. doi: 10.1016/j.ijcard.2012.01.047. Epub 2012 Feb 14. Int J Cardiol. 2013. PMID: 22336254

2

Economic burden and co-morbidities of atrial fibrillation in a privately insured population.

Wu EQ, Birnbaum HG, Mareva M, Tuttle E, Castor AR, Jackman W, Ruskin J. Wu EQ, et al. Curr Med Res Opin. 2005 Oct;21(10):1693-9. doi: 10.1185/030079905X65475. Curr Med Res Opin. 2005. PMID: 16238910 Clinical Trial.

3

Retrospective economic and outcomes analyses using non-US databases: a review.

Shi L, Wu EQ, Hodges M, Yu A, Birnbaum H. Shi L, et al. Among authors: wu eq. Pharmacoeconomics. 2007;25(7):563-76. doi: 10.2165/00019053-200725070-00003. Pharmacoeconomics. 2007. PMID: 17610337 Review.

4

Short-term economic impact of body weight change among patients with type 2 diabetes treated with antidiabetic agents: analysis using claims, laboratory, and medical record data.

Yu AP, Wu EQ, Birnbaum HG, Emani S, Fay M, Pohl G, Wintle M, Yang E, Oglesby A. Yu AP, et al. Among authors: wu eq. Curr Med Res Opin. 2007 Sep;23(9):2157-69. doi: 10.1185/0300799007X219544. Curr Med Res Opin. 2007. PMID: 17669232 Review.

5

The costs of Crohn's disease in the United States and other Western countries: a systematic review.

Yu AP, Cabanilla LA, Wu EQ, Mulani PM, Chao J. Yu AP, et al. Among authors: wu eq. Curr Med Res Opin. 2008 Feb;24(2):319-28. doi: 10.1185/030079908x260790. Curr Med Res Opin. 2008. PMID: 18067689 Review.

6

Disease-related and all-cause health care costs of elderly patients with gout.

Wu EQ, Patel PA, Yu AP, Mody RR, Cahill KE, Tang J, Krishnan E. Wu EQ, et al. J Manag Care Pharm. 2008 Mar;14(2):164-75. doi: 10.18553/jmcp.2008.14.2.164. J Manag Care Pharm. 2008. PMID: 18331118 Free PMC article.

7

Loss of treatment response to infliximab maintenance therapy in Crohn's disease: a payor perspective.

Wu EQ, Mulani PM, Yu AP, Tang J, Pollack PF. Wu EQ, et al. Value Health. 2008 Sep-Oct;11(5):820-9. doi: 10.1111/j.1524-4733.2008.00335.x. Epub 2008 May 16. Value Health. 2008. PMID: 18489509 Free article.

8

Comparison of escitalopram versus citalopram for the treatment of major depressive disorder in a geriatric population.

Wu E, Greenberg PE, Yang E, Yu A, Erder MH. Wu E, et al. Curr Med Res Opin. 2008 Sep;24(9):2587-95. doi: 10.1185/03007990802303525. Epub 2008 Jul 31. Curr Med Res Opin. 2008. PMID: 18674407

9

Comparison of treatment persistence, hospital utilization and costs among major depressive disorder geriatric patients treated with escitalopram versus other SSRI/SNRI antidepressants.

Wu E, Greenberg P, Yang E, Yu A, Ben-Hamadi R, Erder MH. Wu E, et al. Curr Med Res Opin. 2008 Oct;24(10):2805-13. doi: 10.1185/03007990802336780. Epub 2008 Aug 27. Curr Med Res Opin. 2008. PMID: 18755054

10

Effects of adalimumab therapy on incidence of hospitalization and surgery in Crohn's disease: results from the CHARM study.

Feagan BG, Panaccione R, Sandborn WJ, D'Haens GR, Schreiber S, Rutgeerts PJ, Loftus EV Jr, Lomax KG, Yu AP, Wu EQ, Chao J, Mulani P. Feagan BG, et al. Among authors: wu eq. Gastroenterology. 2008 Nov;135(5):1493-9. doi: 10.1053/j.gastro.2008.07.069. Epub 2008 Aug 3. Gastroenterology. 2008. PMID: 18848553 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

266 results

Search Page

Filters